Literature DB >> 26656811

Factors to Govern Soluble and Insoluble Aggregate-formation in Monoclonal Antibodies.

Jun Fukuda1, Takafumi Iwura, Shigehiro Yanagihara, Kenji Kano.   

Abstract

The aggregation formation of monoclonal antibodies as biopharmaceuticals induced by heat stress was evaluated by size-exclusion chromatography, and the formation rate was correlated with several physicochemical parameters of the antibodies to clarify the factors to govern the aggregate formation. The parameters we studied were: the melting temperature (Tm) and the standard enthalpy of the melting point (ΔmH°) evaluated by differential scanning calorimetry under given and common conditions; the wavelength (λmax) and the intensity (Fint) of the maximum fluorescence peak of 1-anilinonaphthalene-8-sulfonate as a probe dye; the z-average diameter (D) evaluated by dynamic light scattering; and the isoelectric point (pI) and the hydrophobic index (Hpho) of the complementarity determining region calculated from the amino acid sequence. Multivariate statistical analysis with these explanatory variables based on Akaike's information criterion indicates that the soluble aggregate formation is negatively correlated with Tm and pI, while the insoluble aggregate formation is positively correlated with Fint and pI. Based on these results, the mechanisms of the aggregate formation and methods to prevent the formation are discussed.

Mesh:

Substances:

Year:  2015        PMID: 26656811     DOI: 10.2116/analsci.31.1233

Source DB:  PubMed          Journal:  Anal Sci        ISSN: 0910-6340            Impact factor:   2.081


  3 in total

Review 1.  Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Jake Pawlowski; Guanbo Wang
Journal:  J Pharm Biomed Anal       Date:  2020-02-12       Impact factor: 3.935

2.  The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodies.

Authors:  Leon F Willis; Amit Kumar; Tushar Jain; Isabelle Caffry; Yingda Xu; Sheena E Radford; Nikil Kapur; Maximiliano Vásquez; David J Brockwell
Journal:  Eng Rep       Date:  2020-03-15

3.  Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics.

Authors:  Patrice Douillard; Michael Freissmuth; Gerhard Antoine; Michael Thiele; Daniel Fleischanderl; Peter Matthiessen; Dirk Voelkel; Randolf J Kerschbaumer; Friedrich Scheiflinger; Nicolas Sabarth
Journal:  Antibodies (Basel)       Date:  2019-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.